Responses
Poster presentations
P135 A phase I, first-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of M5049, a dual antagonist of TLR7/8, in healthy subjects
Compose a Response to This Article
Other responses
No responses have been published for this article.